XOMA Corporation - 8.625% Serie (XOMAP) Financials
XOMAP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 124.1 million | 18.1 million |
2023-06-30 | 125.7 million | 15.5 million |
2023-03-31 | 133.7 million | 19.1 million |
2022-12-31 | 140.4 million | 16.4 million |
XOMAP Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.1 million | 2.7 million |
2023-06-30 | -7.2 million | 2.2 million |
2023-03-31 | -4.9 million | 1.6 million |
2022-12-31 | -3.9 million | 988000 |
XOMAP Net Income
No data available :(
XOMAP Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 33.7 million | - | - |
2023-06-30 | 31.8 million | - | 17000 |
2023-03-31 | 44.6 million | - | 69000 |
2022-12-31 | 58.2 million | - | 34000 |
XOMAP Shares Outstanding
XOMAP Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 25000 | 6.4 million | - |
2023-06-30 | - | 39000 | 5.8 million | - |
2023-03-31 | - | 54000 | 6.2 million | - |
2022-12-31 | 8.0 million | 28000 | 7.6 million | - |
XOMAP Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 830000 | 224000 |
2023-06-30 | 1.7 million | 224000 |
2023-03-31 | 437000 | 225000 |
2022-12-31 | 1.5 million | 97000 |
XOMAP
Price: $24.98
Forward Dividend Yield: 8.63%
Payout Ratio: 215.41%
Dividend Per Share: 2.16 USD
Earnings Per Share: 1.00 USD
P/E Ratio: 25
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1300
Market Capitalization: 234.3 million
Average Dividend Frequency: 4
Years Paying Dividends: 4